Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

AdaptHealth (AHCO) Change in Receivables (2019 - 2026)

AdaptHealth has reported Change in Receivables over the past 7 years, most recently at -$8.8 million for Q4 2025.

For Q4 2025, Change in Receivables fell 163.57% year-over-year to -$8.8 million; the TTM value through Dec 2025 reached -$31.0 million, down 218.19%, while the annual FY2025 figure was -$31.0 million, 218.19% down from the prior year.
Change in Receivables for Q4 2025 was -$8.8 million at AdaptHealth, up from -$13.3 million in the prior quarter.
Over five years, Change in Receivables peaked at $40.6 million in Q1 2024 and troughed at -$35.9 million in Q3 2024.
A 5-year average of $2.7 million and a median of $4.9 million in 2022 define the central range for Change in Receivables.
On a YoY basis, Change in Receivables climbed as much as 1728.53% in 2021 and fell as far as 5800.0% in 2021.
Year by year, Change in Receivables stood at $4.6 million in 2021, then tumbled by 44.79% to $2.6 million in 2022, then surged by 633.4% to $18.8 million in 2023, then dropped by 26.07% to $13.9 million in 2024, then tumbled by 163.57% to -$8.8 million in 2025.
Business Quant data shows Change in Receivables for AHCO at -$8.8 million in Q4 2025, -$13.3 million in Q3 2025, and -$24.3 million in Q2 2025.